NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
4.270
+0.290 (7.29%)
At close: Jan 2, 2026, 4:00 PM EST
4.354
+0.084 (1.97%)
After-hours: Jan 2, 2026, 7:59 PM EST
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $492.29 million as of January 2, 2026. Its market cap has increased by 530.11% in one year.
Market Cap
492.29M
Enterprise Value
267.29M
1-Year Change
530.11%
Ranking
Category
Stock Price
$4.27
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $492.29M, an increase of 256.61%. That is a compound annual growth rate of 23.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 492.29M | 7.29% |
| Dec 31, 2025 | 458.86M | 562.90% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |